+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Blood Glucose Testing Market by Product Type, Technology, Modality, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Blood Glucose Testing Market by Product Type, Technology, Modality, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Blood Glucose Testing Market by Product Type, Technology, Modality, End User, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5094051
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Blood Glucose Testing Market is projected to reach USD 25.81 Billion in 2026. It is expected to continue growing at a CAGR of 10.73%, reaching USD 47.76 Billion by 2032.

Blood glucose testing has become a core pillar of diabetes diagnosis, therapy optimization, and long-term complication prevention. The market spans self-monitoring blood glucose meters, test strips, lancets, continuous glucose monitoring systems, hospital point-of-care analyzers, and connected digital platforms that support clinical decisions across home, retail, laboratory, and acute-care settings.

Demand is anchored by the global diabetes burden. The International Diabetes Federation estimated that 589 million adults were living with diabetes in 2024, with prevalence expected to rise materially by 2050. This expanding patient population, together with wider insulin use, gestational diabetes screening, aging demographics, and the shift toward value-based care, is sustaining the need for accurate, accessible, and interoperable blood glucose testing solutions.

Transformative Shifts in the Blood Glucose Testing Landscape

The blood glucose testing landscape is shifting from episodic fingerstick measurement toward continuous, connected, and patient-centered monitoring. Continuous glucose monitoring is gaining adoption because it provides trend data, time-in-range metrics, and alerts that single-point testing cannot deliver, while traditional blood glucose meters remain essential for affordability, confirmation testing, hospital workflows, and markets with constrained reimbursement.

Regulatory expectations and clinical guidelines are also raising the performance bar. Accuracy standards such as ISO 15197 and national device requirements continue to influence product design, while healthcare systems increasingly prioritize remote monitoring, digital therapeutics integration, and data sharing among patients, clinicians, caregivers, and payers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expanding the value of blood glucose testing from measurement to prediction, personalization, and workflow automation. AI-enabled analytics can identify glycemic patterns, support hypoglycemia risk alerts, improve insulin titration recommendations, and help clinicians prioritize patients who need intervention, particularly when combined with continuous glucose monitoring, electronic health records, and connected insulin delivery systems.

The cumulative impact is strongest where algorithms are validated, explainable, and integrated into regulated clinical pathways. Industry leaders must balance innovation with cybersecurity, data privacy, bias monitoring, and clinical evidence generation, because glucose data can directly influence medication decisions and patient safety.

Key Regional Insights

Asia-Pacific is one of the most important growth engines for blood glucose testing due to large diabetes populations in China, India, Japan, South Korea, and Australia, alongside rising diagnosis rates and expanding private healthcare access. The region combines high-volume demand for affordable meters and strips with accelerating uptake of connected glucose monitoring in urban and insured populations.

North America remains a high-value market supported by advanced reimbursement structures, strong adoption of continuous glucose monitoring, and a mature ecosystem of endocrinology practices, pharmacies, and digital health platforms. Europe benefits from structured diabetes care pathways, national health systems, and regulatory harmonization, while Latin America shows steady demand as Brazil and Mexico scale access to diabetes screening and chronic disease management.

The Middle East is advancing through government-led diabetes prevention strategies, high per-capita healthcare spending in several Gulf states, and hospital modernization. Africa presents a long-term access opportunity, where affordability, primary-care diagnostics, supply reliability, and diabetes education are critical to improving glucose testing penetration and supporting earlier disease management.

Key Group Insights

ASEAN markets are characterized by rising urbanization, growing type 2 diabetes prevalence, and a need for cost-effective blood glucose testing that can serve both primary care and home monitoring. The GCC is differentiated by high diabetes prevalence, strong public health investment, and rapid adoption of hospital-based and connected diabetes technologies.

The European Union supports market consistency through medical device regulation, procurement standards, and established chronic care systems, while BRICS countries represent scale-driven demand across large populations with varied reimbursement and infrastructure maturity. G7 markets continue to lead in premium device adoption, evidence-based reimbursement, and digital integration, whereas NATO member countries collectively reflect strong hospital procurement capacity, coordinated healthcare infrastructure, and growing emphasis on medical supply resilience.

Key Country Insights

The United States is the most commercially mature country for advanced blood glucose testing, supported by broad continuous glucose monitoring adoption, pharmacy distribution, remote patient monitoring, and payer coverage for eligible populations. Canada benefits from provincial reimbursement pathways and strong clinical guideline adoption, while Mexico and Brazil show rising demand tied to expanding diabetes diagnosis, urban healthcare access, and private-sector participation.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain structured diabetes management programs, with Germany and France particularly important for reimbursement-led technology adoption. Russia remains a sizable market where domestic distribution, procurement policies, and economic constraints shape device availability.

China and India represent the largest volume opportunities due to their diabetes populations, with affordability and distribution breadth central to market success. Japan, Australia, and South Korea are advanced markets with strong healthcare infrastructure, high technology acceptance, and growing use of connected monitoring solutions across home care and specialist diabetes management.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated accuracy, affordability, and seamless data interoperability. Portfolio strategies should include both low-cost self-monitoring solutions for high-volume markets and premium continuous glucose monitoring platforms for patients who benefit from trend-based decision support.

Organizations should expand partnerships with payers, pharmacies, telehealth providers, and diabetes clinics to improve adherence and recurring utilization. Investment in patient education, multilingual applications, supply-chain redundancy, cybersecurity, and real-world evidence will strengthen market access and support sustainable differentiation.

Research Methodology

This executive summary is based on secondary research from recognized public health agencies, regulatory frameworks, clinical guidelines, reimbursement policies, and peer-reviewed evidence on diabetes monitoring. Key reference points include global diabetes prevalence estimates, device accuracy standards, healthcare utilization patterns, and adoption trends for self-monitoring and continuous glucose monitoring.

Findings were synthesized using triangulation across disease burden, technology adoption, reimbursement maturity, regional healthcare infrastructure, and clinical positioning. The methodology emphasizes verified, data-backed insights and avoids speculative projections that cannot be supported by credible industry or public health evidence.

Conclusion

Blood glucose testing is moving from a device-led category to a connected diabetes management ecosystem. Accurate meters and strips remain indispensable, while continuous glucose monitoring and AI-enabled analytics are redefining how patients, clinicians, and payers interpret glycemic control.

The strongest opportunities will belong to organizations that combine regulatory-grade performance, accessible pricing, digital integration, and evidence-based outcomes. As diabetes prevalence continues to rise worldwide, blood glucose testing will remain central to preventive care, treatment optimization, and chronic disease management.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Blood Glucose Testing Market, by Product Type
7.1. Blood Glucose Meters
7.2. Control Solutions
7.3. Lancets
7.4. Sensors
7.4.1. Continuous Glucose Monitoring Sensors
7.4.2. Flash Glucose Monitoring Sensors
7.5. Test Strips
8. Blood Glucose Testing Market, by Technology
8.1. Electrochemical Sensors
8.2. Optical Techniques
8.3. Thermal Techniques
9. Blood Glucose Testing Market, by Modality
9.1. Point-of-Care Testing (POCT)
9.1.1. Hospital Bedside Testing
9.1.2. Clinic-Based Testing
9.2. Home Care Testing
9.2.1. Personal Glucose Monitoring Devices
9.2.2. Wearable CGM Devices
9.3. Laboratory-Based Testing
9.3.1. Fasting Plasma Glucose (FPG)
9.3.2. Oral Glucose Tolerance Test (OGTT)
9.3.3. HbA1c Testing
10. Blood Glucose Testing Market, by End User
10.1. Diagnostic Laboratories
10.2. Home Care
10.3. Hospitals And Clinics
11. Blood Glucose Testing Market, by Distribution Channel
11.1. Offline
11.2. Online
12. Asia-Pacific Blood Glucose Testing Market
13. North America Blood Glucose Testing Market
14. Latin America Blood Glucose Testing Market
15. Europe Blood Glucose Testing Market
16. Middle East Blood Glucose Testing Market
17. Africa Blood Glucose Testing Market
18. ASEAN Blood Glucose Testing Market
19. GCC Blood Glucose Testing Market
20. European Union Blood Glucose Testing Market
21. BRICS Blood Glucose Testing Market
22. G7 Blood Glucose Testing Market
23. NATO Blood Glucose Testing Market
24. United States Blood Glucose Testing Market
25. Canada Blood Glucose Testing Market
26. Mexico Blood Glucose Testing Market
27. Brazil Blood Glucose Testing Market
28. United Kingdom Blood Glucose Testing Market
29. Germany Blood Glucose Testing Market
30. France Blood Glucose Testing Market
31. Russia Blood Glucose Testing Market
32. Italy Blood Glucose Testing Market
33. Spain Blood Glucose Testing Market
34. China Blood Glucose Testing Market
35. India Blood Glucose Testing Market
36. Japan Blood Glucose Testing Market
37. Australia Blood Glucose Testing Market
38. South Korea Blood Glucose Testing Market
39. Competitive Landscape
39.1. Market Concentration Analysis, 2025
39.1.1. Concentration Ratio (CR)
39.1.2. Herfindahl Hirschman Index (HHI)
39.2. Recent Developments & Impact Analysis, 2025
39.3. Product Portfolio Analysis, 2025
39.4. Benchmarking Analysis, 2025
40. Company Profiles
40.1. 77 Elektronika Kft.
40.2. Abbott Laboratories
40.3. ACON Laboratories, Inc
40.4. AgaMatrix, Inc.
40.5. ARKRAY, Inc.
40.6. Ascensia Diabetes Care Holdings AG
40.7. B. Braun Medical Ltd.
40.8. Becton Dickinson and Company
40.9. Beurer Belgium
40.10. Dexcom, Inc.
40.11. ForaCare Suisse AG
40.12. i-SENS, Inc.
40.13. Johnson & Johnson
40.14. LifeScan IP Holdings, LLC
40.15. Medisana AG
40.16. Medtronic PLC
40.17. Merck KGaA
40.18. Microlife AG
40.19. Neogen Corporation
40.20. Nipro Corporation
40.21. Nova Biomedical
40.22. Omron Healthcare, Inc.
40.23. Roche Diagnostics Nederland BV
40.24. Rossmax International Ltd.
40.25. Sanofi S.A.
40.26. Sinocare Inc.
40.27. Terumo Corporation
40.28. Trividia Health, Inc.
40.29. VivaChek Laboratories Inc.
List of Figures
FIGURE 1. GLOBAL BLOOD GLUCOSE TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BLOOD GLUCOSE TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 23. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 25. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 37. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 49. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 50. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BLOOD GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLOOD GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL BLOOD GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLOOD GLUCOSE METERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CONTROL SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CONTROL SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CONTROL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL LANCETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL LANCETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING SENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING SENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITORING SENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FLASH GLUCOSE MONITORING SENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FLASH GLUCOSE MONITORING SENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FLASH GLUCOSE MONITORING SENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL TEST STRIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL TEST STRIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ELECTROCHEMICAL SENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ELECTROCHEMICAL SENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ELECTROCHEMICAL SENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL OPTICAL TECHNIQUES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL OPTICAL TECHNIQUES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL OPTICAL TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL THERMAL TECHNIQUES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL THERMAL TECHNIQUES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THERMAL TECHNIQUES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL POINT-OF-CARE TESTING (POCT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL POINT-OF-CARE TESTING (POCT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL POINT-OF-CARE TESTING (POCT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HOSPITAL BEDSIDE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HOSPITAL BEDSIDE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HOSPITAL BEDSIDE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CLINIC-BASED TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CLINIC-BASED TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CLINIC-BASED TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HOME CARE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HOME CARE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HOME CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PERSONAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PERSONAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PERSONAL GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL WEARABLE CGM DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL WEARABLE CGM DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL WEARABLE CGM DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL LABORATORY-BASED TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FASTING PLASMA GLUCOSE (FPG) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FASTING PLASMA GLUCOSE (FPG) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL FASTING PLASMA GLUCOSE (FPG) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ORAL GLUCOSE TOLERANCE TEST (OGTT) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ORAL GLUCOSE TOLERANCE TEST (OGTT) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ORAL GLUCOSE TOLERANCE TEST (OGTT) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HBA1C TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HBA1C TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HBA1C TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 123. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 124. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 125. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 126. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. EUROPE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 140. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 141. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 142. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 143. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 144. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 145. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 146. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. AFRICA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 150. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 151. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 152. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 153. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 154. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 155. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 156. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. ASEAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 161. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 162. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 163. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 164. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 165. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 166. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. GCC BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 179. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 181. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 182. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 183. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 184. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 185. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 186. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. BRICS BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 191. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 192. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 193. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 194. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 195. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 196. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. G7 BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 199. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 201. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 203. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 204. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 205. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 206. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. NATO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 219. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 221. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 222. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 223. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 224. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 225. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 226. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. CANADA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 229. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 230. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 231. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 233. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 234. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 235. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 236. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. MEXICO BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 238. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 239. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 240. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 241. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 243. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 244. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 245. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 246. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 247. BRAZIL BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 248. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 249. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 250. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 251. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 252. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 253. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 254. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 255. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 256. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. UNITED KINGDOM BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 258. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 259. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 260. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 261. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 262. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 263. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 264. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 265. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 266. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 267. GERMANY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 268. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 270. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 271. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 272. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 273. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 274. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 275. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 276. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 277. FRANCE BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 278. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 279. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 280. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 281. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 282. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 283. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 284. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 285. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 286. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. RUSSIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 288. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 289. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 290. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 291. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 292. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 293. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 294. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 295. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 296. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 297. ITALY BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 298. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 299. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 300. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 301. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 302. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 303. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 304. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 305. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 306. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 307. SPAIN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 308. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 309. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 310. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 311. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 312. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 313. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 314. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 315. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 316. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 317. CHINA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 318. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 319. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 320. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 321. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 322. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 323. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 324. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 325. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 326. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 327. INDIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 328. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 329. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 330. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 331. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 332. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 333. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 334. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 335. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 336. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 337. JAPAN BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 338. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 339. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 340. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 341. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 342. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
TABLE 343. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY POINT-OF-CARE TESTING (POCT), 2018-2032 (USD MILLION)
TABLE 344. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY HOME CARE TESTING, 2018-2032 (USD MILLION)
TABLE 345. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY LABORATORY-BASED TESTING, 2018-2032 (USD MILLION)
TABLE 346. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 347. AUSTRALIA BLOOD GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 348. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 349. SOUTH KOREA BLOOD GLUCOSE TESTING MARKET SIZE, BY P

Companies Mentioned

The companies featured in this Blood Glucose Testing market report include:
  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Medical Ltd.
  • Becton Dickinson and Company
  • Beurer Belgium
  • Dexcom, Inc.
  • ForaCare Suisse AG
  • i-SENS, Inc.
  • Johnson & Johnson
  • LifeScan IP Holdings, LLC
  • Medisana AG
  • Medtronic PLC
  • Merck KGaA
  • Microlife AG
  • Neogen Corporation
  • Nipro Corporation
  • Nova Biomedical
  • Omron Healthcare, Inc.
  • Roche Diagnostics Nederland BV
  • Rossmax International Ltd.
  • Sanofi S.A.
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • VivaChek Laboratories Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 25.81 Billion
Forecasted Market Value ( USD ) by 2032 $ 47.76 Billion
Compound Annual Growth Rate10.7%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Blood Glucose Lancets Market - Global Forecast 2026-2032 - Product Image

Blood Glucose Lancets Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Continuous Blood Glucose Monitoring Systems Market by Product, Technology, End User, Distribution Channel, Application - Global Forecast 2026-2032 - Product Image

Continuous Blood Glucose Monitoring Systems Market by Product, Technology, End User, Distribution Channel, Application - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Blood Glucose Monitoring Systems - Global Strategic Business Report - Product Image

Blood Glucose Monitoring Systems - Global Strategic Business Report

  • Report
  • 456 Pages
  • Global
From
Blood Glucose Test Strips - Global Strategic Business Report - Product Image

Blood Glucose Test Strips - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Blood Glucose Test Strips Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.